A study that analyzed new diagnoses of type 2 diabetes after suffering from COVID-19 found that there would be a relationship between the pandemic infection and the chronic condition.
Research conducted in Germany found an increased incidence of diagnoses by 28% in people recovered from a mild form of COVID-19.
Although more research is needed in a wide variety of population groups, the scientists say their finding shows the need to integrate COVID treatment with diabetes care, and to ensure that glucose tests are performed on patients who are undergoing diabetes. recovering from the infection, in order to detect any abnormalities.
The researchers, who analyzed 35,865 cases of German COVID-19 patients, indicated that there are still a number of unanswered questions for future research. Between them:
- It is unclear whether pre-existing diabetes becomes apparent during the time a person is sick with COVID-19 as a consequence of immune activation or stress hyperglycemia.
- Whether post-COVID diabetes can be reversed after full recovery needs to be investigated.
- Management of new-onset diabetes after COVID-19 should be evaluated. Diabetic ketoacidosis has been observed in some people without diabetes, diagnosed even months after recovery from infection.
Studies carried out in 2020 had already put the magnifying glass in this possible association between COVID-19 and type 2 diabetes.
COVID-19 infection would impact the functioning of the pancreas, and, consequently, the production of insulin, the gland that produces the pancreas and that enables and regulates the way the body uses glucose.
It is estimated that around 32 million people live with diabetes in the region of the Americas, and the projection of the International Diabetes Federation is that there will be 40 million by 2030.
In the United States, 37 million people are living with diabetes, but one in 5 don’t know it. About 96 million American adults have prediabetes.
Minorities have dramatically higher rates of diabetes and later diagnoses.